Shandong Sito Bio-technology Co., Ltd. (SHE:300583)
17.80
-0.15 (-0.84%)
May 30, 2025, 3:04 PM CST
SHE:300583 Revenue
Shandong Sito Bio-technology had revenue of 259.85M CNY in the quarter ending March 31, 2025, with 6.32% growth. This brings the company's revenue in the last twelve months to 986.06M, down -17.10% year-over-year. In the year 2024, Shandong Sito Bio-technology had annual revenue of 970.60M, down -24.16%.
Revenue (ttm)
986.06M
Revenue Growth
-17.10%
P/S Ratio
3.42
Revenue / Employee
1.03M
Employees
959
Market Cap
3.38B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 970.60M | -309.18M | -24.16% |
Dec 31, 2023 | 1.28B | -32.33M | -2.46% |
Jan 1, 2023 | 1.31B | 109.49M | 9.10% |
Jan 1, 2022 | 1.20B | 289.44M | 31.70% |
Dec 31, 2020 | 913.19M | -52.61M | -5.45% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |